Health Canada drug identification number

DIN 02248965 — FABRAZYME 5 MG

FABRAZYME is a powder for solution of Agalsidase beta marketed by SANOFI-AVENTIS CANADA INC. The full Agalsidase beta monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02248965
Brand name
FABRAZYME
Active ingredient
Agalsidase beta
Strength
5 MG
Dosage form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Manufacturer
SANOFI-AVENTIS CANADA INC
Health Canada status
MARKETED
Drug class
Enzyme replacement therapy (alpha-galactosidase A)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Agalsidase beta products

DINBrandStrengthFormManufacturerStatus
02248966 FABRAZYME 35 MG POWDER FOR SOLUTION SANOFI-AVENTIS CANADA INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.